APA (7th ed.) Citation

Gerson, J., Castillo-Carranza, D., Sengupta, U., Henson, N., Nilson, A., & Kayed, R. (2015). Tau oligomer antibodies as potential therapeutics for parkinson’s and other synucleinopathies. Journal of the Neurological Sciences, 357, e10. https://doi.org/10.1016/j.jns.2015.08.110

Chicago Style (17th ed.) Citation

Gerson, J., D.L Castillo-Carranza, U. Sengupta, N. Henson, A. Nilson, and R. Kayed. "Tau Oligomer Antibodies as Potential Therapeutics for Parkinson’s and Other Synucleinopathies." Journal of the Neurological Sciences 357 (2015): e10. https://doi.org/10.1016/j.jns.2015.08.110.

MLA (9th ed.) Citation

Gerson, J., et al. "Tau Oligomer Antibodies as Potential Therapeutics for Parkinson’s and Other Synucleinopathies." Journal of the Neurological Sciences, vol. 357, 2015, p. e10, https://doi.org/10.1016/j.jns.2015.08.110.